Shanghai M&G (603899) Report Interpretation

Overview

This earnings review assesses Shanghai M&G’s 2Q26 results and management briefing. Goldman Sachs sees a mixed quarter: subdued Colipu demand, higher selling expenses, tax and finance costs caused a net-profit miss, while product mix and cost control supported a stronger-than-expected gross margin. It maintains Buy with a Rmb27 target price.

Core views

Shanghai M&G reported 2Q26 revenue of Rmb5.789bn, up 4% year-on-year but 3% below Goldman Sachs estimates. Net profit attributable to shareholders was Rmb249mn, also up 4% year-on-year but 3% below estimates. The shortfall was concentrated in Colipu: its sales increased 3.4% year-on-year but were 6% below estimates, while gross margin remained under pressure at 6.5%, down 31bp year-on-year. Other products, writing instruments and direct office-supply sales also missed estimates, whereas school stationery and office stationery outperformed them. The principal positive was profitability above the gross-profit line. Operating profit reached Rmb324mn, 15% above Goldman Sachs estimates and up 29% year-on-year. Gross margin was 18.9%, 78bp above estimates and 59bp higher year-on-year, helped by product mix. Traditional core sales were slightly ahead of estimates, with gross margin 1.1 percentage points above expectations, reflecting continued mix improvement and stronger bargaining power. Administrative expenses also improved, with the ratio at 4.8%, down 27bp year-on-year. However, selling expenses were 8.5% of revenue, 28bp higher year-on-year and 32bp above estimates; higher finance costs, foreign-exchange losses and a higher-than-expected tax rate left net margin flat year-on-year at 4.3%. Management expects a better second half under its “one body, two wings” strategy. For Colipu, it notes that the first half normally accounts for about 40% of annual revenue and procurement demand is weighted toward the fourth quarter. Management expects business-mix optimization and larger procurement scale to improve profitability, though the benefits from a higher self-operated sales mix are more likely to become visible in 2027. It targets a self-operated mix above 20% in 2026, from the teens previously. MRO is viewed as Colipu’s largest growth opportunity, supported by centralized procurement and domestic substitution among state-owned enterprises; the company has added a dedicated MRO team and is discussing potential targets, while retaining an asset-light approach. In the traditional core business, growth improved from an approximately 3% year-on-year decline in 1Q26 to approximately 3% growth in 2Q26. The report attributes this to better execution in classic writing products across roughly 70,000 offline terminals, a strong exam season and growth in new IP stationery. Average selling prices rose about 2-3%, primarily through mix rather than price increases. Management sees further scope for share gains despite demographic pressure, citing an approximately 20% share of its core stationery market. Jiumu reached net-profit breakeven in 1H26 after team, product and store adjustments and closures of lower-quality stores. Expansion has been slower than Goldman Sachs expected because management prioritizes quality. Jiumu has 12 large-format stores, generally larger than 250 square metres versus 120-150 square metres for traditional stores, and management considers the large-store model financially viable based on several stores. Second-half openings should emphasize these larger stores, while the customer proposition broadens from young women toward K12 families and adds high-frequency essentials. The retail big-shops business generated Rmb432mn of 2Q26 revenue, up 14% year-on-year; Jiumu contributed Rmb425mn, up 16% year-on-year, partly offset by a decline at M&G Life. Overseas, management identifies Southeast Asia as the main growth market, expecting approximately 20-30% growth and continued outperformance versus other regions; Africa is described as a longer-term opportunity. Management also expects to maintain a stable, relatively high dividend payout over the next two to three years, with cancellation and equity incentives remaining possible uses for repurchased shares. Goldman Sachs lowered 2026-28E net-profit estimates by 4-6%, reflecting softer demand, higher selling expenses and a higher tax rate, partly offset by better gross margin and administrative savings. Its revised revenue forecasts are Rmb26.189bn for 2026E, Rmb27.838bn for 2027E and Rmb29.508bn for 2028E, reductions of 3.0%, 3.8% and 5.0% from prior forecasts. Revised EPS is Rmb1.54, Rmb1.73 and Rmb1.88 for 2026E-2028E. The target price falls to Rmb27 from Rmb28, based on an unchanged 17x 2026E P/E multiple, while the Buy rating is maintained.

Analysis framework

Goldman Sachs compares reported quarterly revenue, margins, operating profit and net profit with its estimates, identifies performance by business line, then incorporates management’s outlook for Colipu, Jiumu, core stationery and overseas operations. It revises multi-year earnings forecasts for demand, expense and tax assumptions, and values the shares using 17x 2026E P/E.

Methodology notes

• Valuation methodsP/E and PEG Valuation

  17x 2026E P/E valuation

  The target price is derived by applying an unchanged 17x multiple to Goldman Sachs’ 2026 estimated earnings per share.

• Industry AnalysisVolume-price decomposition

  Product mix, average selling price and gross-margin analysis

  The report links gross-margin improvement to a higher mix of classic writing products and notes that average selling prices rose about 2-3% mainly because of mix rather than price increases.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Shanghai M&G (603899.SH)

  Primary covered company; Goldman Sachs maintains a Buy rating following a 2Q26 earnings miss.

  Strengths

  Resilient traditional-core revenue, gross-margin expansion, improved administrative-expense control, Jiumu breakeven and overseas growth potential.

  Weaknesses

  Colipu sales were below expectations and its gross margin remained pressured; selling expenses, tax and finance costs weighed on net profit.

  Comparison

  Traditional core business was slightly ahead of Goldman Sachs estimates, while Colipu was 6% below estimates.

  Risks

  Slower-than-expected product-mix upgrade and more intense competition in Stationery and Office Supplies.

Key data

• 2Q26 revenueRmb5,789mnUp 4% year-on-year and 3% below Goldman Sachs estimates.
• 2Q26 net profit attributable to shareholdersRmb249mnUp 4% year-on-year and 3% below Goldman Sachs estimates.
• 2Q26 gross margin18.9%78bp above Goldman Sachs estimates and 59bp higher year-on-year.
• 2Q26 operating profitRmb324mnUp 29% year-on-year and 15% above Goldman Sachs estimates.
• Colipu 2Q26 sales growth3.4% year-on-yearSales were 6% below Goldman Sachs estimates; gross margin was 6.5%.
• 2026E EPSRmb1.54Reduced from Rmb1.61, a 4.4% cut.
• 2026E revenueRmb26,189mnReduced by 3.0% from the prior forecast.

Impact & implications

Goldman Sachs argues that core-stationery mix improvement and gross-margin resilience partly offset weaker Colipu demand and elevated selling, tax and finance costs. It expects the earnings impact to persist in revised 2026-28 estimates, while management’s back-end-loaded Colipu demand, Jiumu store upgrades and Southeast Asian growth provide potential operational support.

Risks

• Product-mix upgrades may be slower than expected.
• Competition in the Stationery and Office Supplies businesses may intensify.